Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario: A Retrospective and Prospective, Multicenter, Two Cohorts Study

NCT06836219 is registered in ClinicalTrials.gov with Consorzio Oncotech as lead sponsor.

NCT NCT06836219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06836219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario: A Retrospective and Prospective, Multicenter, Two Cohorts Study
Lead sponsor
Consorzio Oncotech
Phase
Observational
Overall status
Recruiting
Start date
September 13, 2024
Completion date
January 31, 2029
Enrollment
300 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer